Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) for the reporting period ending September 2, 2022. The filing addresses a regulatory compliance issue regarding the company's listing status on the Nasdaq Global Select Market.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status rather than financial performance metrics.
Material Changes
- Delisting Notice: On September 2, 2022, the company received a notification from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to a delay in filing its Annual Report on Form 10-K for the fiscal year ended May 29, 2022.
- Trading Status: The notice has no immediate effect on the listing or trading of the company's common stock.
Guidance, Outlook, and Risks
Management Commentary and Plan: The company states it is working diligently to complete the 2022 Form 10-K and plans to file it as promptly as possible. It has 60 calendar days (until November 1, 2022) to submit a plan to regain compliance. If accepted, Nasdaq may grant up to 180 days from the original due date (until February 28, 2023) to file the report.
Risks and Contingencies: The filing highlights significant risks, including the inability to respond timely to Nasdaq inquiries, the failure to regain compliance with listing rules, and the possibility that filing the 2022 Form 10-K will take longer than expected, potentially leading to delisting.
Investor Verification Checklist
- Verify the current status of the 2022 Form 10-K filing with the SEC.
- Monitor whether the company submits a compliance plan to Nasdaq by the November 1, 2022 deadline.
- Check for any subsequent 8-K filings regarding the acceptance or rejection of the compliance plan by Nasdaq.
- Review the company's most recent available financial statements to assess liquidity and operational health, as this filing contains no financial data.